Chargement en cours...
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
Multiple myeloma (MM) is an incurable B-cell malignancy. Therefore, new targets and drugs are urgently needed to improve patient outcome. Epigenetic aberrations play a crucial role in development and progression in cancer, including MM. To target these aberrations, epigenetic modulating agents, such...
Enregistré dans:
Auteurs principaux: | , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
MDPI
2013
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3730337/ https://ncbi.nlm.nih.gov/pubmed/24216985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers5020430 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|